ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
3
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
3
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Paliperidone Palmitate Injection Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-19E17127
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Paliperidone Palmitate Injection Market Research Report 2024
BUY CHAPTERS

Global Paliperidone Palmitate Injection Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-19E17127
Report
November 2025
Pages:115
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Janssen Pharmaceuticals (Johnson & Johnson)
Qilu Pharmaceutical
Shandong Lvye Pharmaceutical
Janssen Pharmaceuticals (Johnson & Johnson)

Paliperidone Palmitate Injection Market

The global Paliperidone Palmitate Injection market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Paliperidone is an atypical antipsychotic. It is mainly used to treat schizophrenia and schizoaffective disorder. Paliperidone palmitate is a long-acting injectable formulation of paliperidone palmitoyl ester. It is on the World Health Organization's List of Essential Medicines. Paliperidone is available as a generic medication.
From a downstream perspective, Hospital accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Paliperidone Palmitate Injection leading manufacturers including Janssen Pharmaceuticals (Johnson & Johnson), Qilu Pharmaceutical, Shandong Lvye Pharmaceutical, etc., dominate supply; the top five capture approximately % of global revenue, with Janssen Pharmaceuticals (Johnson & Johnson) leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Paliperidone Palmitate Injection market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Paliperidone Palmitate Injection Market Report

Report Metric Details
Report Name Paliperidone Palmitate Injection Market
Segment by Type
  • 1-month Formulation
  • 3-month Formulation
  • 6-month Formulation
Segment by Application
  • Hospital
  • Psychiatric Hospital
  • Others
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Janssen Pharmaceuticals (Johnson & Johnson), Qilu Pharmaceutical, Shandong Lvye Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Paliperidone Palmitate Injection study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Paliperidone Palmitate Injection Market report?

Ans: The main players in the Paliperidone Palmitate Injection Market are Janssen Pharmaceuticals (Johnson & Johnson), Qilu Pharmaceutical, Shandong Lvye Pharmaceutical

What are the Application segmentation covered in the Paliperidone Palmitate Injection Market report?

Ans: The Applications covered in the Paliperidone Palmitate Injection Market report are Hospital, Psychiatric Hospital, Others

What are the Type segmentation covered in the Paliperidone Palmitate Injection Market report?

Ans: The Types covered in the Paliperidone Palmitate Injection Market report are 1-month Formulation, 3-month Formulation, 6-month Formulation

1 Study Coverage
1.1 Introduction to Paliperidone Palmitate Injection: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Paliperidone Palmitate Injection Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 1-month Formulation
1.2.3 3-month Formulation
1.2.4 6-month Formulation
1.3 Market Segmentation by Application
1.3.1 Global Paliperidone Palmitate Injection Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Psychiatric Hospital
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Paliperidone Palmitate Injection Revenue Estimates and Forecasts 2020-2031
2.2 Global Paliperidone Palmitate Injection Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Paliperidone Palmitate Injection Sales Estimates and Forecasts 2020-2031
2.4 Global Paliperidone Palmitate Injection Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Paliperidone Palmitate Injection Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Paliperidone Palmitate Injection Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 1-month Formulation Market Size by Manufacturers
3.5.2 3-month Formulation Market Size by Manufacturers
3.5.3 6-month Formulation Market Size by Manufacturers
3.6 Global Paliperidone Palmitate Injection Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Paliperidone Palmitate Injection Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Paliperidone Palmitate Injection Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Paliperidone Palmitate Injection Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Paliperidone Palmitate Injection Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Paliperidone Palmitate Injection Sales and Revenue by Type (2020-2031)
6.4 North America Paliperidone Palmitate Injection Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Paliperidone Palmitate Injection Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Paliperidone Palmitate Injection Sales and Revenue by Type (2020-2031)
7.4 Europe Paliperidone Palmitate Injection Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Paliperidone Palmitate Injection Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Paliperidone Palmitate Injection Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Paliperidone Palmitate Injection Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Paliperidone Palmitate Injection Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Paliperidone Palmitate Injection Sales and Revenue by Type (2020-2031)
9.4 Central and South America Paliperidone Palmitate Injection Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Paliperidone Palmitate Injection Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Paliperidone Palmitate Injection Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Paliperidone Palmitate Injection Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Paliperidone Palmitate Injection Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Janssen Pharmaceuticals (Johnson & Johnson)
11.1.1 Janssen Pharmaceuticals (Johnson & Johnson) Corporation Information
11.1.2 Janssen Pharmaceuticals (Johnson & Johnson) Business Overview
11.1.3 Janssen Pharmaceuticals (Johnson & Johnson) Paliperidone Palmitate Injection Product Models, Descriptions and Specifications
11.1.4 Janssen Pharmaceuticals (Johnson & Johnson) Paliperidone Palmitate Injection Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Janssen Pharmaceuticals (Johnson & Johnson) Paliperidone Palmitate Injection Sales by Product in 2024
11.1.6 Janssen Pharmaceuticals (Johnson & Johnson) Paliperidone Palmitate Injection Sales by Application in 2024
11.1.7 Janssen Pharmaceuticals (Johnson & Johnson) Paliperidone Palmitate Injection Sales by Geographic Area in 2024
11.1.8 Janssen Pharmaceuticals (Johnson & Johnson) Paliperidone Palmitate Injection SWOT Analysis
11.1.9 Janssen Pharmaceuticals (Johnson & Johnson) Recent Developments
11.2 Qilu Pharmaceutical
11.2.1 Qilu Pharmaceutical Corporation Information
11.2.2 Qilu Pharmaceutical Business Overview
11.2.3 Qilu Pharmaceutical Paliperidone Palmitate Injection Product Models, Descriptions and Specifications
11.2.4 Qilu Pharmaceutical Paliperidone Palmitate Injection Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Qilu Pharmaceutical Paliperidone Palmitate Injection Sales by Product in 2024
11.2.6 Qilu Pharmaceutical Paliperidone Palmitate Injection Sales by Application in 2024
11.2.7 Qilu Pharmaceutical Paliperidone Palmitate Injection Sales by Geographic Area in 2024
11.2.8 Qilu Pharmaceutical Paliperidone Palmitate Injection SWOT Analysis
11.2.9 Qilu Pharmaceutical Recent Developments
11.3 Shandong Lvye Pharmaceutical
11.3.1 Shandong Lvye Pharmaceutical Corporation Information
11.3.2 Shandong Lvye Pharmaceutical Business Overview
11.3.3 Shandong Lvye Pharmaceutical Paliperidone Palmitate Injection Product Models, Descriptions and Specifications
11.3.4 Shandong Lvye Pharmaceutical Paliperidone Palmitate Injection Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Shandong Lvye Pharmaceutical Paliperidone Palmitate Injection Sales by Product in 2024
11.3.6 Shandong Lvye Pharmaceutical Paliperidone Palmitate Injection Sales by Application in 2024
11.3.7 Shandong Lvye Pharmaceutical Paliperidone Palmitate Injection Sales by Geographic Area in 2024
11.3.8 Shandong Lvye Pharmaceutical Paliperidone Palmitate Injection SWOT Analysis
11.3.9 Shandong Lvye Pharmaceutical Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Paliperidone Palmitate Injection Industry Chain
12.2 Paliperidone Palmitate Injection Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Paliperidone Palmitate Injection Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Paliperidone Palmitate Injection Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Paliperidone Palmitate Injection Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Paliperidone Palmitate Injection Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Janssen Pharmaceuticals (Johnson & Johnson)
Qilu Pharmaceutical
Shandong Lvye Pharmaceutical
Janssen Pharmaceuticals (Johnson & Johnson)
List of Tables
 Table 1. Global Paliperidone Palmitate Injection Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Paliperidone Palmitate Injection Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Paliperidone Palmitate Injection Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Paliperidone Palmitate Injection Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Paliperidone Palmitate Injection Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Paliperidone Palmitate Injection Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)
 Table 7. Global Paliperidone Palmitate Injection Sales by Region (2020-2025) & (K Units)
 Table 8. Global Paliperidone Palmitate Injection Sales by Region (2026-2031) & (K Units)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Paliperidone Palmitate Injection Sales by Manufacturers (2020-2025) & (K Units)
 Table 11. Global Paliperidone Palmitate Injection Sales Share by Manufacturers (2020-2025)
 Table 12. Global Paliperidone Palmitate Injection Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Paliperidone Palmitate Injection Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Paliperidone Palmitate Injection by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Paliperidone Palmitate Injection as of 2024)
 Table 16. Global Paliperidone Palmitate Injection Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Paliperidone Palmitate Injection Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)
 Table 18. Key Manufacturers Paliperidone Palmitate Injection Manufacturing Base and Headquarters
 Table 19. Global Paliperidone Palmitate Injection Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Paliperidone Palmitate Injection Sales by Type (2020-2025) & (K Units)
 Table 23. Global Paliperidone Palmitate Injection Sales by Type (2026-2031) & (K Units)
 Table 24. Global Paliperidone Palmitate Injection Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Paliperidone Palmitate Injection Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Paliperidone Palmitate Injection ASP by Type (2020-2031) & (US$/Unit)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Paliperidone Palmitate Injection Sales by Application (2020-2025) & (K Units)
 Table 29. Global Paliperidone Palmitate Injection Sales by Application (2026-2031) & (K Units)
 Table 30. Paliperidone Palmitate Injection High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Paliperidone Palmitate Injection Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Paliperidone Palmitate Injection Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Paliperidone Palmitate Injection ASP by Application (2020-2031) & (US$/Unit)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Paliperidone Palmitate Injection Growth Accelerators and Market Barriers
 Table 37. North America Paliperidone Palmitate Injection Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Paliperidone Palmitate Injection Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Paliperidone Palmitate Injection Growth Accelerators and Market Barriers
 Table 40. Europe Paliperidone Palmitate Injection Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Paliperidone Palmitate Injection Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Paliperidone Palmitate Injection Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Paliperidone Palmitate Injection Sales (K Units) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Paliperidone Palmitate Injection Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Paliperidone Palmitate Injection Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Paliperidone Palmitate Injection Investment Opportunities and Key Challenges
 Table 47. Central and South America Paliperidone Palmitate Injection Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Paliperidone Palmitate Injection Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Paliperidone Palmitate Injection Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Janssen Pharmaceuticals (Johnson & Johnson) Corporation Information
 Table 51. Janssen Pharmaceuticals (Johnson & Johnson) Description and Major Businesses
 Table 52. Janssen Pharmaceuticals (Johnson & Johnson) Product Models, Descriptions and Specifications
 Table 53. Janssen Pharmaceuticals (Johnson & Johnson) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 54. Janssen Pharmaceuticals (Johnson & Johnson) Sales Value Proportion by Product in 2024
 Table 55. Janssen Pharmaceuticals (Johnson & Johnson) Sales Value Proportion by Application in 2024
 Table 56. Janssen Pharmaceuticals (Johnson & Johnson) Sales Value Proportion by Geographic Area in 2024
 Table 57. Janssen Pharmaceuticals (Johnson & Johnson) Paliperidone Palmitate Injection SWOT Analysis
 Table 58. Janssen Pharmaceuticals (Johnson & Johnson) Recent Developments
 Table 59. Qilu Pharmaceutical Corporation Information
 Table 60. Qilu Pharmaceutical Description and Major Businesses
 Table 61. Qilu Pharmaceutical Product Models, Descriptions and Specifications
 Table 62. Qilu Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 63. Qilu Pharmaceutical Sales Value Proportion by Product in 2024
 Table 64. Qilu Pharmaceutical Sales Value Proportion by Application in 2024
 Table 65. Qilu Pharmaceutical Sales Value Proportion by Geographic Area in 2024
 Table 66. Qilu Pharmaceutical Paliperidone Palmitate Injection SWOT Analysis
 Table 67. Qilu Pharmaceutical Recent Developments
 Table 68. Shandong Lvye Pharmaceutical Corporation Information
 Table 69. Shandong Lvye Pharmaceutical Description and Major Businesses
 Table 70. Shandong Lvye Pharmaceutical Product Models, Descriptions and Specifications
 Table 71. Shandong Lvye Pharmaceutical Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 72. Shandong Lvye Pharmaceutical Sales Value Proportion by Product in 2024
 Table 73. Shandong Lvye Pharmaceutical Sales Value Proportion by Application in 2024
 Table 74. Shandong Lvye Pharmaceutical Sales Value Proportion by Geographic Area in 2024
 Table 75. Shandong Lvye Pharmaceutical Paliperidone Palmitate Injection SWOT Analysis
 Table 76. Shandong Lvye Pharmaceutical Recent Developments
 Table 77. Key Raw Materials Distribution
 Table 78. Raw Materials Key Suppliers
 Table 79. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 80. Milestones in Production Technology Evolution
 Table 81. Distributors List
 Table 82. Market Trends and Market Evolution
 Table 83. Market Drivers and Opportunities
 Table 84. Market Challenges, Risks, and Restraints
 Table 85. Research Programs/Design for This Report
 Table 86. Key Data Information from Secondary Sources
 Table 87. Key Data Information from Primary Sources


List of Figures
 Figure 1. Paliperidone Palmitate Injection Product Picture
 Figure 2. Global Paliperidone Palmitate Injection Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. 1-month Formulation Product Picture
 Figure 4. 3-month Formulation Product Picture
 Figure 5. 6-month Formulation Product Picture
 Figure 6. Global Paliperidone Palmitate Injection Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 7. Hospital
 Figure 8. Psychiatric Hospital
 Figure 9. Others
 Figure 10. Paliperidone Palmitate Injection Report Years Considered
 Figure 11. Global Paliperidone Palmitate Injection Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Paliperidone Palmitate Injection Revenue (2020-2031) & (US$ Million)
 Figure 13. Global Paliperidone Palmitate Injection Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 14. Global Paliperidone Palmitate Injection Revenue Market Share by Region (2020-2031)
 Figure 15. Global Paliperidone Palmitate Injection Sales (2020-2031) & (K Units)
 Figure 16. Global Paliperidone Palmitate Injection Sales (CAGR) by Region (2020-2031) (K Units)
 Figure 17. Global Paliperidone Palmitate Injection Sales Market Share by Region (2020-2031)
 Figure 18. Top 5 and Top 10 Manufacturers Paliperidone Palmitate Injection Sales Volume Market Share in 2024
 Figure 19. Global Paliperidone Palmitate Injection Revenue Market Share Ranking (2024)
 Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 21. 1-month Formulation Revenue Market Share by Manufacturer in 2024
 Figure 22. 3-month Formulation Revenue Market Share by Manufacturer in 2024
 Figure 23. 6-month Formulation Revenue Market Share by Manufacturer in 2024
 Figure 24. Global Paliperidone Palmitate Injection Sales Market Share by Type (2020-2031)
 Figure 25. Global Paliperidone Palmitate Injection Revenue Market Share by Type (2020-2031)
 Figure 26. Global Paliperidone Palmitate Injection Sales Market Share by Application (2020-2031)
 Figure 27. Global Paliperidone Palmitate Injection Revenue Market Share by Application (2020-2031)
 Figure 28. North America Paliperidone Palmitate Injection Sales YoY (2020-2031) & (K Units)
 Figure 29. North America Paliperidone Palmitate Injection Revenue YoY (2020-2031) & (US$ Million)
 Figure 30. North America Top 5 Manufacturers Paliperidone Palmitate Injection Sales Revenue (US$ Million) in 2024
 Figure 31. North America Paliperidone Palmitate Injection Sales Volume (K Units) by Type (2020- 2031)
 Figure 32. North America Paliperidone Palmitate Injection Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 33. North America Paliperidone Palmitate Injection Sales Volume (K Units) by Application (2020-2031)
 Figure 34. North America Paliperidone Palmitate Injection Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 35. US Paliperidone Palmitate Injection Revenue (2020-2031) & (US$ Million)
 Figure 36. Canada Paliperidone Palmitate Injection Revenue (2020-2031) & (US$ Million)
 Figure 37. Mexico Paliperidone Palmitate Injection Revenue (2020-2031) & (US$ Million)
 Figure 38. Europe Paliperidone Palmitate Injection Sales YoY (2020-2031) & (K Units)
 Figure 39. Europe Paliperidone Palmitate Injection Revenue YoY (2020-2031) & (US$ Million)
 Figure 40. Europe Top 5 Manufacturers Paliperidone Palmitate Injection Sales Revenue (US$ Million) in 2024
 Figure 41. Europe Paliperidone Palmitate Injection Sales Volume (K Units) by Type (2020-2031)
 Figure 42. Europe Paliperidone Palmitate Injection Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 43. Europe Paliperidone Palmitate Injection Sales Volume (K Units) by Application (2020-2031)
 Figure 44. Europe Paliperidone Palmitate Injection Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 45. Germany Paliperidone Palmitate Injection Revenue (2020-2031) & (US$ Million)
 Figure 46. France Paliperidone Palmitate Injection Revenue (2020-2031) & (US$ Million)
 Figure 47. U.K. Paliperidone Palmitate Injection Revenue (2020-2031) & (US$ Million)
 Figure 48. Italy Paliperidone Palmitate Injection Revenue (2020-2031) & (US$ Million)
 Figure 49. Russia Paliperidone Palmitate Injection Revenue (2020-2031) & (US$ Million)
 Figure 50. Asia-Pacific Paliperidone Palmitate Injection Sales YoY (2020-2031) & (K Units)
 Figure 51. Asia-Pacific Paliperidone Palmitate Injection Revenue YoY (2020-2031) & (US$ Million)
 Figure 52. Asia-Pacific Top 8 Manufacturers Paliperidone Palmitate Injection Sales Revenue (US$ Million) in 2024
 Figure 53. Asia-Pacific Paliperidone Palmitate Injection Sales Volume (K Units) by Type (2020- 2031)
 Figure 54. Asia-Pacific Paliperidone Palmitate Injection Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 55. Asia-Pacific Paliperidone Palmitate Injection Sales Volume (K Units) by Application (2020-2031)
 Figure 56. Asia-Pacific Paliperidone Palmitate Injection Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 57. Indonesia Paliperidone Palmitate Injection Revenue (2020-2031) & (US$ Million)
 Figure 58. Japan Paliperidone Palmitate Injection Revenue (2020-2031) & (US$ Million)
 Figure 59. South Korea Paliperidone Palmitate Injection Revenue (2020-2031) & (US$ Million)
 Figure 60. China Taiwan Paliperidone Palmitate Injection Revenue (2020-2031) & (US$ Million)
 Figure 61. India Paliperidone Palmitate Injection Revenue (2020-2031) & (US$ Million)
 Figure 62. Central and South America Paliperidone Palmitate Injection Sales YoY (2020-2031) & (K Units)
 Figure 63. Central and South America Paliperidone Palmitate Injection Revenue YoY (2020-2031) & (US$ Million)
 Figure 64. Central and South America Top 5 Manufacturers Paliperidone Palmitate Injection Sales Revenue (US$ Million) in 2024
 Figure 65. Central and South America Paliperidone Palmitate Injection Sales Volume (K Units) by Type (2021-2031)
 Figure 66. Central and South America Paliperidone Palmitate Injection Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 67. Central and South America Paliperidone Palmitate Injection Sales Volume (K Units) by Application (2020-2031)
 Figure 68. Central and South America Paliperidone Palmitate Injection Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 69. Brazil Paliperidone Palmitate Injection Revenue (2020-2025) & (US$ Million)
 Figure 70. Argentina Paliperidone Palmitate Injection Revenue (2020-2025) & (US$ Million)
 Figure 71. Middle East, and Africa Paliperidone Palmitate Injection Sales YoY (2020-2031) & (K Units)
 Figure 72. Middle East and Africa Paliperidone Palmitate Injection Revenue YoY (2020-2031) & (US$ Million)
 Figure 73. Middle East and Africa Top 5 Manufacturers Paliperidone Palmitate Injection Sales Revenue (US$ Million) in 2024
 Figure 74. Middle East and Africa Paliperidone Palmitate Injection Sales Volume (K Units) by Type (2021-2031)
 Figure 75. South America Paliperidone Palmitate Injection Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 76. Middle East and Africa Paliperidone Palmitate Injection Sales Volume (K Units) by Application (2020-2031)
 Figure 77. Middle East and Africa Paliperidone Palmitate Injection Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 78. GCC Countries Paliperidone Palmitate Injection Revenue (2020-2025) & (US$ Million)
 Figure 79. Turkey Paliperidone Palmitate Injection Revenue (2020-2025) & (US$ Million)
 Figure 80. Egypt Paliperidone Palmitate Injection Revenue (2020-2025) & (US$ Million)
 Figure 81. South Africa Paliperidone Palmitate Injection Revenue (2020-2025) & (US$ Million)
 Figure 82. Paliperidone Palmitate Injection Industry Chain Mapping
 Figure 83. Regional Paliperidone Palmitate Injection Manufacturing Base Distribution (%)
 Figure 84. Global Paliperidone Palmitate Injection Production Market Share by Region (2020-2031)
 Figure 85. Paliperidone Palmitate Injection Production Process
 Figure 86. Regional Paliperidone Palmitate Injection Production Cost Structure
 Figure 87. Channels of Distribution (Direct Vs Distribution)
 Figure 88. Bottom-up and Top-down Approaches for This Report
 Figure 89. Data Triangulation
 Figure 90. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Bioinformatics Barcelona

SIMILAR REPORTS

Global Paliperidone Palmitate API Market Research Report 2024
Global Paliperidone Palmitate Reagent Market Research Report 2024
Global Paliperidone Market Insights Forecast to 2030
Global Ziprasidone Mesylate for Injection Market Research Report 2024
Global Long acting Injectable Antipsychotics LAIs Market Research Report 2024
Global Risperidone Microspheres for Injection Market Research Report 2024
Paliperidone Extended Release Tablets Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Quetiapine Fumarate Market Insights Forecast to 2030
Global Ziprasidone Drugs Market Research Report 2024
Long Acting Injectable LAI Antipsychotic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Risperidone API Market Research Report 2025
Pharmaceutical Grade Paliperidone Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Paliperidone API Market Research Report 2025
Global Olanzapine Tablets Market Research Report 2024
Global Risperidone Market Research Report 2024
Global Quetiapine Fumarate Tablets Market Research Report 2024
Global Dexamethasone Palmitate Injection Market Research Report 2024
Global Aripiprazole Drug Market Insights Forecast to 2030
Long acting Injectable Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Trifluoperazine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Levothyroxine Sodium Tablets Hormone Medication Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-25N19924
Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Needle Free Allergy Therapy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-24B19783
Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Hydrotalcite Antacid Chewable Tablets Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-10T20305
Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Dual Orexin Receptor Antagonist Sleeping Pills Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-12S20176
Mon Nov 24 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions